Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
- Written by PR Newswire
- US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology.
- LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines.
- Exopharm is seeking potential partners and licensees, with LEAP™ having the...